Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease
Background Current studies suggest mitochondrial dysfunction is a major contributor to impaired physical performance and exercise intolerance in chronic kidney disease (CKD). We conducted a clinical trial of coenzyme Q10 (CoQ10) and nicotinamide riboside (NR) to determine their impact on exercise to...
Main Authors: | Armin Ahmadi, Gwenaelle Begue, Ana P. Valencia, Jennifer E. Norman, Benjamin Lidgard, Brian J. Bennett, Matthew P. Van Doren, David J. Marcinek, Sili Fan, David K. Prince, Jorge Gamboa, Jonathan Himmelfarb, Ian H. de Boer, Bryan R. Kestenbaum, Baback Roshanravan |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2023-06-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.167274 |
Similar Items
-
Assessment of kidney proximal tubular secretion in critical illness
by: Pavan K. Bhatraju, et al.
Published: (2021-05-01) -
Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
by: Rachel S. Fletcher, et al.
Published: (2017-08-01) -
Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients
by: Kumar Sharma, et al.
Published: (2023-10-01) -
Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD<sup>+</sup> by Generating Dihydronicotinamide Riboside
by: Eleonora Ciarlo, et al.
Published: (2022-07-01) -
Emerging Role of Nicotinamide Riboside in Health and Diseases
by: Chiranjeev Sharma, et al.
Published: (2022-09-01)